Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
about
The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.A novel domperidone hydrogel: preparation, characterization, pharmacokinetic, and pharmacodynamic properties.Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.Solid dispersions, part II: new strategies in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs.In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility.Improved albendazole dissolution rate in pluronic 188 solid dispersions.Solid-state characterization of lacidipine/PVP K(29/32) solid dispersion primed by solvent co-evaporation.Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.Solid dispersions of imidazolidinedione by PEG and PVP polymers with potential antischistosomal activities.Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers.Hot melt extruded amorphous solid dispersion of posaconazole with improved bioavailability: investigating drug-polymer miscibility with advanced characterisation.In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride.Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization.Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions.Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.Interactive mixture as a rapid drug delivery system.Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions.Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan.Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.Development and optimization of osmotically controlled asymmetric membrane capsules for delivery of solid dispersion of lycopene.Hot Melt Extrusion: A Process Overview and Use in Manufacturing Solid Dispersions of Poorly Water-Soluble DrugsSolubility enhancement of miconazole nitrate: binary and ternary mixture approachSolid Dispersion: An Alternative Technique for Bioavailability Enhancement of Poorly Soluble DrugsCharacterization and Physical Stability of Spray Dried Solid Dispersions of Probucol and PVP-K30Development and Evaluation of Cefadroxyl Monohydrate Solid Dispersion via Solvent Evaporation Method: Investigating Drug-Polymer Miscibility with Advanced CharacterizationMangosteen pericarp extract embedded in electrospun PVP nanofiber mats: physicochemical properties and release mechanism of α-mangostin
P2860
Q31161857-7B4D33F7-543C-40CB-B4E6-4216E3125D7BQ34429157-56936503-49CF-40E1-B8B7-37AC222A0269Q34730346-58A71937-03F4-4C3E-A15E-2F15411B0562Q35592271-5AFF7169-38E8-4B40-A72A-9DB4105FDFA8Q37802897-6AFD616D-C323-4358-BF7D-BBB5AD954B8FQ37932559-93CECEC6-FB1C-48B2-AFEB-D205369890B5Q37932560-273D7F6B-CFEF-47F4-A2A9-BCB76D4EE3A6Q38050160-0870273A-A6B2-4C16-BC4D-CC1E3401318CQ38312135-1535564B-AF76-4867-AE71-E9188A0737EFQ38475312-5FFD02BF-34E2-47D3-8A3B-F1889F745B70Q38856754-5C6B6753-8BF2-4CDE-8DC1-3560085A4079Q39860106-594DF45A-86E6-457A-879F-7950BDD24CBBQ41060331-54525F81-3796-4A8F-9DCF-F1AD63C6DCCCQ41335984-9A56D35A-985B-45D7-BA97-09EC57E3BB77Q41500235-08F54DCE-3E81-4A13-9539-98EC232D2946Q41674945-BA3A37A9-D8FD-4749-8C9D-8B58E0D2A7F2Q41725344-EF5A248C-4A5E-406B-8636-8AFB6EC5FAB3Q41822052-6248862E-6EB7-4D4A-853E-E24B0CFFC43DQ41988628-B212F373-3D60-4DC3-A515-A1E702E608C8Q42024752-6A545486-5DF6-4BCE-878A-7BED9862CFF5Q42114941-0721A367-A340-48A6-B61B-9FBDE6853598Q42152991-983A9EF0-137C-4257-A9D9-E04F7E7A979CQ42315486-265426CB-23E5-4076-846B-08B65794F14AQ43282508-0656B87A-3C94-4724-AB98-0A7CFE31B069Q44860929-775358E4-4624-4D85-A39D-04B9D5E4263CQ45953237-BD02CF0A-3BE5-4A0F-8032-44A8C535FD40Q46732386-0EC13FCD-3B2C-4A8F-8F9B-6E9B127E3E01Q46776168-1420160C-C630-45A5-AE97-EEF0D0D8EC11Q48175399-9A228E66-BC98-4805-BD87-E6CFC2CEEC76Q50556856-EBB02E3C-968A-4DE2-A01E-142C24668682Q50799182-F143F668-9F72-49FA-B74A-749A17286694Q55101339-2D38522D-B562-47EA-9D5D-5EBB9C770293Q57340445-10D1AA87-0CE7-4E85-9603-299D35175AD3Q57349951-70A951E7-0556-47CF-84BE-F9B63A01155BQ57378058-476A9AB6-78D5-4B73-B800-1EEC3D37C9F8Q58199113-0BD15863-E217-46EA-A862-410C85D787A5Q58261654-93425BAA-5ECD-4BEF-AD0A-1E69EB32781FQ58781567-D67FA06E-B014-4811-B7AB-467A4A8160F2
P2860
Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Investigation of the release m ...... and drug-polymer interactions.
@ast
Investigation of the release m ...... and drug-polymer interactions.
@en
type
label
Investigation of the release m ...... and drug-polymer interactions.
@ast
Investigation of the release m ...... and drug-polymer interactions.
@en
prefLabel
Investigation of the release m ...... and drug-polymer interactions.
@ast
Investigation of the release m ...... and drug-polymer interactions.
@en
P2093
P1476
Investigation of the release m ...... and drug-polymer interactions.
@en
P2093
Dimitrios Bikiaris
Emmanuel Georgarakis
Evangelos Karavas
Konstantinos Avgoustakis
Michael P Sigalas
P304
P356
10.1016/J.EJPB.2006.11.020
P407
P577
2006-12-01T00:00:00Z